Is Invitae a Buy?

Zhiyuan Sun, The Motley Fool
·3 min read
Is Invitae a Buy?

Invitae (NYSE: NVTA) has become a favorite of ARK Investment Management, a famous Tesla bull in the electric vehicle manufacturer's early days. ARK Invest owns 27 million shares of Invitae. Invitae's gene testing technology analyzes health data after screening patients' samples (such as blood, saliva, etc.).